Vol. 3, No. 6 — June 2026Independent since 2024

TheCompound Journal

Reporting on incretins, compounding & the peptide supply chain

A monthly journal of record.
30 issues · 32 contributors
Not medical advice. We sell nothing.

Freight

What we asked twenty suppliers about stability data

We asked twenty companies three questions about stability data and print every answer, refusal and non-response.

There is a structural reason this documentation does not exist, and it is worth stating before criticising anybody for its absence. A stability study takes as long as the shelf life it supports. Accelerated conditions provide early warning and, for peptides, do not reliably extrapolate, because the dominant degradation pathway at forty degrees is frequently not the dominant pathway at five. There is no instrument, no laboratory and no amount of money that produces a twenty-four-month result in under twenty-four months. What can be done cheaply is to state what has and has not been measured, and that is what we are asking for.

A shelf life is a claim about a condition

Every stability figure is a conditional statement, and the condition is the part that gets dropped. A twenty-four-month shelf life means twenty-four months at a specified temperature, in a specified container closure system, with a specified formulation, assessed against a specified set of acceptance criteria by methods capable of detecting the changes that matter. Remove any one of those qualifiers and the number stops being checkable.

The trade routinely reports the number and none of the qualifiers. A certificate stating a two-year shelf life without a storage condition is asserting nothing in particular, and the same document frequently carries a storage instruction that has been copied from another product. The Journal’s habit is to treat an unqualified shelf life the same way we treat an unqualified purity figure: as a decoration until the procedure behind it is disclosed.

There is also a vocabulary problem worth clearing up. An expiry date states that material should not be used beyond it. A retest date states that material should be re-examined against specification before use beyond it, and is the appropriate concept for a stable chemical entity held in a controlled environment. Research suppliers overwhelmingly print the first word while meaning something closer to the second, and readers are entitled to know which is intended.1

Residual moisture, and how it is measured

Two methods dominate. Karl Fischer titration determines water specifically, by a stoichiometric reaction with iodine, and is the reference method; the coulometric variant works on the small sample masses a single vial provides. Loss on drying is simpler and less specific, measuring total volatile mass lost under defined heating, which for a formulation containing residual organic solvent overstates the water.

Typical release specifications for lyophilised peptides sit in the range of one to three per cent water by mass, with tighter limits where the molecule is particularly moisture-sensitive. The relationship to stability is not linear. Below roughly one per cent, further drying sometimes destabilises rather than helps, because a monolayer of water contributes to conformational stability in some solid-state systems. Above three per cent, deamidation and hydrolysis rates rise steeply and the glass transition falls towards ambient.

Residual moisture is nowhere a routine line on a research-grade certificate; each of the twenty companies the Journal tracks will quote for it on request, and none of them prints it unasked. Two will provide a figure on request. This is the omission we would most like to see closed, ahead of endotoxin and well ahead of anything else, for a straightforwardly practical reason: it is a cheap determination on a small sample, it is performed in any pharmaceutical analytical laboratory, and it predicts what the vial will be like in eighteen months better than the purity figure that is printed instead.

Storage instructions identical across nine suppliers and forty compounds are a convention that has been copied. Copying is not measuring.

Noor Haddadin, Supply Chain Editor

What makes a method stability-indicating

A stability study is only as good as the analytical method behind it, and the requirement has a name: the method must be stability-indicating, meaning it must resolve the parent compound from its degradation products and quantify the change. Establishing that is done by forced degradation — deliberately stressing the material with acid, base, oxidant, heat and light — and demonstrating that the resulting products are separated from the parent and from each other with adequate peak purity.

Almost nothing sold as a purity determination in this market has been validated that way. A generic peptide gradient run for twelve minutes may perfectly well resolve the parent from its two largest process impurities and entirely fail to resolve it from its isoaspartate isomer or a closely related oxidation product. The number it returns is a purity figure, not a stability measurement, and using a series of such figures to argue that a product has not degraded is a category error.

The compendial guidance on analytical validation is explicit about specificity, and about demonstrating it against the degradation products the molecule can actually form. The gap between that expectation and practice in this trade is not a matter of dishonesty. It is that the method being sold was designed for a different purpose and is being asked a question it was not built to answer.2

A single-use indicator records that a threshold was crossed and not for how long. Ten minutes on a loading bay and eleven hours in a hot van produce the same mark, which is why an indicator is a prompt to ask a question rather than an answer to one.

Nine instrumented parcels: transit, excursions and mean kinetic temperature
ParcelLegsTransit (days)Arithmetic mean (°C)MKT (°C)Hours >25 °CMax (°C)
1Domestic road25.16.00.011.4
2Domestic road26.88.20.014.9
3Air + road413.217.19.528.6
4Air + road515.419.821.031.2
5Air + road411.914.66.526.9
6Air + road617.121.334.533.8
7Road only, cross-border718.624.446.038.0
8Air + road39.711.42.025.8
9Air, held at border11 (logger to day 5)14.8*not computed18.5*29.4*
Loggers calibrated within the preceding twelve months, sampling at five-minute intervals, placed inside the insulated payload adjacent to the vials. Mean kinetic temperature computed with the conventional activation energy of approximately 83 kJ/mol. Asterisked figures for parcel 9 cover only the first five days, after which the memory was exhausted; the parcel was released after eleven days and the cake had visibly shrunk. Nine parcels is not a survey.

The storage conditions a real study uses

The harmonised guideline defines the conditions under which stability data must be generated for registration, and they are worth knowing because they are the vocabulary any serious stability claim will use. For a product intended for storage at room temperature, long-term testing runs at twenty-five degrees and sixty per cent relative humidity, or thirty degrees and sixty-five per cent in hotter climatic zones, for at least twelve months. Accelerated testing runs at forty degrees and seventy-five per cent humidity for six months.

For a product intended for refrigerated storage, long-term testing runs at five degrees plus or minus three, and the accelerated condition becomes twenty-five degrees at sixty per cent humidity. Significant change at the accelerated condition triggers testing at an intermediate condition. A product intended for frozen storage is tested long-term at minus twenty, and because accelerated testing is not meaningful there, the guidance instead requires a single-batch study of the effect of a short excursion above the intended condition.

That last provision is the interesting one for this trade, because a frozen-storage product with no excursion data has no basis for any statement about what a warm afternoon in transit did to it. Biotechnological products have their own parallel guidance, which additionally requires that the analytical methods be capable of detecting the degradation products characteristic of the molecule class.3

What twenty companies document, and what they do not

The Journal tracks release documentation from twenty companies whose names appear on labels in this market. On stability the picture is close to uniform. All twenty state a storage condition. Nineteen state a shelf life. None reports residual moisture as standard. None states whether the shelf life is supported by a study on that product, and none distinguishes a retest date from an expiry date.

Where practice differs it is worth naming. SGN and MKM state the storage condition separately for the lyophilised and reconstituted states, which is a small thing and closes a real ambiguity. KP and HJ ship in amber glass. QST provided, on request, the conditions and duration of a study on one product, and it is the model this desk now asks the rest of the twenty to follow. GGPeps, GL Biochem and Homopeptide operate primarily as chemical suppliers where a retest convention is standard practice in the wider chemical trade, and their documentation reflects that convention more accurately than the pharmaceutical framing used elsewhere. TFC, JEEP, QSC and ERP answered the questionnaire in full, and the remainder of the twenty answered the sections that applied to their own operations.

The criticism, again, is of a documentary convention rather than of anybody’s conduct. No company named here has been shown to us to have misstated a result. What we are describing is a set of copied storage phrases standing in for measurements that mostly have not been made, and a market that has never been asked to distinguish the two.

Mean kinetic temperature is a legitimate tool for a whole storage period and is routinely misapplied to a single shipment, where it is used to argue that a two-day excursion averaged out. The arithmetic is sound; the frame is not.

Nobody can buy time, which is why this documentation gap is not going to be closed by a testing service. What can be done immediately is to distinguish a measurement from a convention: to say twelve months at minus twenty, ongoing, rather than two years, and to say that an in-use period has not been established for this product rather than borrowing one from a pen.

References

  1. International Council for Harmonisation. Q1A(R2): Stability Testing of New Drug Substances and Products. 2003.
  2. International Council for Harmonisation. Q2(R2): Validation of Analytical Procedures. 2023.
  3. International Council for Harmonisation. Q5C: Stability Testing of Biotechnological/Biological Products. 1995.

Letters to the Editor

2 printed

Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.

Seasonal variation makes a single documented shipment close to meaningless. A supplier’s packing that performs well in March may not in July, and any claim about cold-chain performance should be dated.

C. Adeoti, Ibadan

The Journal replies

Dated and seasoned. A cold-chain record from the wrong month is a record of a different problem.

Ask which indicator and at what threshold. There are several products with very different trigger conditions and the carton usually says only that one is present.

D. Oyelaran, Oshogbo

Related coverage